SCREENING FOR ADVANCED FIBROSIS AMONG ALASKA NATIVE PEOPLES WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

被引：0
|
作者：
Johnston, Janet [1 ]
Barbour, Youssef [1 ]
Townshend-Bulson, Lisa [2 ]
Desai, Kena [1 ]
Homan, Chriss [1 ]
Rhodes, Wileina [1 ]
McMahon, Brian [3 ]
机构：
[1] Alaska Nat Tribal Hlth Consortiu, Anchorage, AK USA
[2] Alaska Nat Tribal Consortium, Anchorage, AK USA
[3] Alaska Native Med Ctr, Anchorage, AK USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
748
引用
收藏
页码：S558 / S559
页数：2
相关论文
共 50 条
  • [1] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
  • [2] Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Sogbe, Miguel
    Hummer, Breianna
    Stine, Jonathan G.
    Lizaola-Mayo, Blanca
    Forman, Daniel E.
    Vargas, Hugo E.
    Duarte-Rojo, Andres
    DIGESTIVE DISEASES AND SCIENCES, 2025, : 1530 - 1539
  • [3] Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Is Independently Associated With Reduced Renal Function
    Villarroel, Carolina
    Karim, Gres
    Sehmbhi, Mantej
    Debroff, Jake
    Weisberg, Ilan
    Dinani, Amreen
    GASTRO HEP ADVANCES, 2024, 3 (01): : 122 - 127
  • [4] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [5] Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Chen, Jiaxin
    Jian, Linge
    Guo, Yangkun
    Tang, Chengwei
    Huang, Zhiyin
    Gao, Jinhang
    ANTIOXIDANTS, 2024, 13 (06)
  • [6] PRESENCE OF SARCOPENIA AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF ADVANCED HEPATIC FIBROSIS
    Habig, Gregory
    Smaltz, Christa
    Bilello, Justin
    Monsuruddin, Shahir A.
    Guglielmo, Flavius
    Halpern, Ethan J.
    Halegoua-De Marzio, Dina
    GASTROENTEROLOGY, 2024, 166 (05) : S475 - S476
  • [7] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    HEPATOLOGY, 2023,
  • [8] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Orfanidou, Myrsini
    Polyzos, Stergios A.
    MEDICINA-LITHUANIA, 2025, 61 (01):
  • [9] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [10] Metabolic dysfunction-associated steatotic liver disease in adults
    Huang, Daniel Q.
    Wong, Vincent W. S.
    Rinella, Mary E.
    Boursier, Jerome
    Lazarus, Jeffrey V.
    Yki-Jarvinen, Hannele
    Loomba, Rohit
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
12345